2115. Rezafungin Activity against Invasive Candidiasis Isolates Globally: Results from the 2022 Rezafungin Surveillance Program

por Carvalhaes, Cecilia G, Rhomberg, Paul, Klauer, Abby, Castanheira, Mariana
Publicado 2023

1947. Activity of Rezafungin against Echinocandin–Non-wild type C. glabrata Clinical Isolates from the Rezafungin Surveillance Program (2014–2021)

por Carvalhaes, Cecilia G, Rhomberg, Paul, Klauer, Abby, Deshpande, Lalitagauri M, Castanheira, Mariana
Publicado 2023

2113. Evaluation of Isavuconazole Activity against Aspergillus fumigatus Causing Invasive Infections Worldwide Using the New CLSI Clinical Breakpoints

por Carvalhaes, Cecilia G, Rhomberg, Paul, Klauer, Abby L, Hatch, Beth, Castanheira, Mariana
Publicado 2023

1044. In vitro Activity of Tebipenem Against Relevant Clinical Isolates in the Presence of Pulmonary Surfactant

por Arends, S J Ryan, Klauer, Abby L, Cotroneo, Nicole, Critchley, Ian A, Mendes, Rodrigo E
Publicado 2021

1041. In vitro activity of tebipenem against a recent collection of fastidious organisms recovered from respiratory tract infections

por Arends, S J Ryan, Klauer, Abby L, Cotroneo, Nicole, Critchley, Ian A, Mendes, Rodrigo E
Publicado 2021

1038. In Vitro Activity of Tebipenem, an Orally Available Carbapenem Agent, Against a Collection of Surveillance Gram-Positive Clinical Isolates

por Arends, S J Ryan, Klauer, Abby L, Cotroneo, Nicole, Critchley, Ian A, Mendes, Rodrigo E
Publicado 2021

1731. Rezafungin Activity against Candida spp. and Aspergillus spp. Isolates Causing Invasive Infections Worldwide in 2021

por Carvalhaes, Cecilia G, Rhomberg, Paul, Rhomberg, Paul, Strand, Greg, Klauer, Abby L, Castanheira, Mariana
Publicado 2022